Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Icon link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Advocacy Action Center

National Eczema Awareness Month

In September 2017, NEA launched its advocacy program, Raise Your Voice! We asked members of our community to email their elected officials to let them know that eczema is an important public health issue. We also asked people who participated in this campaign to request that their representatives sponsor a resolution declaring October, Eczema Awareness Month. Our campaign met with resounding success.

Grassroots advocates in Georgia, Tennessee, Illinois, Pennsylvania, Michigan, Louisiana, and Oklahoma met with their elected representatives and successfully pushed through an Eczema Awareness Month resolution. We are convinced that we can get resolutions passed in at least seven states in 2019, but we need your help.

Would you be willing to help make October Eczema Awareness Month in your state? In most states, the process is very strait forward. And, NEA’s automated, online advocacy system makes identifying and e-mailing your elected representatives very simple.

If you are willing to help raise eczema awareness, please take action here, or contact VP of Advocacy and Access, Tim Smith.

Legislative Positions

Step Therapy

Have you ever been prescribed a medication by your doctor just to be told by your insurer that you have to take another medication first? If you have, then you’ve experienced step therapy.

Step therapy is a protocol that insurers use to steer patients away from the medications prescribed by their doctors and toward cheaper medications. Essentially, insurers deny coverage for patients’ prescribed medications unless the patients try cheaper drugs for a period of time first. This protocol has the effect of discouraging patients from trying to get the medicines they need to manage their conditions. You can find our more about step therapy here: https://youtu.be/zg6mjEnUMv0.

The National Eczema Association believes that this practice is wrong and is working with coalitions in several states and at the federal level of government to pass legislation which requires insurers step therapy protocols to be rational and in keeping with standards of good medical practice. Currently, NEA supports the following step therapy bills:

Updated February 21, 2019

Georgia – HB 63 (Cooper)
Crossed over – In Senate

Would require insurers’ step therapy protocols to be consistent with the standards of good medical practice and that the insurers provide exceptions from step therapy protocols under certain conditions, such as when a patient is likely to adverse reaction to a step medication or when the medication is not likely to work given the patient’s medical history.

If you live in Georgia, please click the “Take Action” button to tell your legislators that you support step therapy reform.
Take Action

Oregon – HB 2668 (Malstrom)
Introduced

Comprehensive bill that would require insurers’ step therapy protocols to be consistent with the standards of good medical practice and that the insurers provide exceptions from step therapy protocols under certain conditions. It would also require insurers to implement web-based application procedures for prior authorization applications and impose minimum response times on insurers.

If you live in Oregon, please click the “Take Action” button to tell your legislators that you support step therapy reform.
Take Action

Virginia – HB 2126 (Davis)
Crossed over – In Senate

Would require insurers’ step therapy protocols to be consistent with the standards of good medical practice and that the insurers provide exceptions from step therapy protocols under certain conditions, such as when a patient is likely to adverse reaction to a step medication or when the medication is not likely to work given the patient’s medical history.

If you live in Virginia, please click the “Take Action” button to tell your elected representatives that you support step therapy reform.
Take Action

Massachusetts – HB 1506 (Benson) and SD 2096 (Cyr)
Introduced

These are concurrent bills that would require insurers’ step therapy protocols to be consistent with the standards of good medical practice and that the insurers provide exceptions from step therapy protocols under certain conditions, such as when a patient is likely to adverse reaction to a step medication or when the medication is not likely to work given the patient’s medical history.

If you live in Massachusetts, please click the “Take Action” button to tell your elected representatives that you support step therapy reform.
Take Action

Washington – HB 1879 and SB 5806
HB 1879 voted out of policy committee
SB 5806 scheduled for hearing

These are concurrent bills that would require insurers’ step therapy protocols to be consistent with the standards of good medical practice and that the insurers provide exceptions from step therapy protocols under certain conditions, such as when a patient is likely to adverse reaction to a step medication or when the medication is not likely to work given the patient’s medical history.

If you live in Washington, please click the “Take Action” button to tell your elected representatives that you support step therapy reform.
Take Action

North Dakota – HB 1469 (Mock)
Introduced

Would amend existing statutes governing the operation of the state’s Medicaid program to make them conform with proposed federal step therapy requirements for the Medicaid program.

New Mexico – SB 112 (Steffanics)
Introduced

Would amend existing statute to shorten the timeframe in which insurers have to provide notification of formulary changes.

Oklahoma – SB 509 (Radder)
Introduced

Would require insurers’ step therapy protocols to be consistent with the standards of good medical practice and that the insurers provide exceptions from step therapy protocols under certain conditions, such as when a patient is likely to adverse reaction to a step medication or when the medication is not likely to work given the patient’s medical history.